Variable | ≤ 42 NVIQ group | > 42 NVIQ group |
---|---|---|
N | 8 (0 female) | 6 (4 female) |
Age range | 9–32 years | 10–22 years |
Mean age (SD) | 16.38 (± 7.37) | 14.34 (± 4.08) |
NVIQ range | 32–42 | 52–93 |
Mean NVIQ (SD) | 38 (± 3.64) | 62 (± 10.02) |
Medication | N = 6 Methylphenidate (36–45 mg qd) (4) Amphetamine mixed salts (50 mg qd) (1) Venlafaxine (75 mg qd) (1) | N = 3 Methylphenidate (36–50 mg qd) (2) Atomoxetine (25–40 mg qd) (2) Citalopram (20 mg qd) (1) |
Comorbidities | Autistic spectrum disorder (4) Attention-deficit hyperactivity disorder (6) | Autistic spectrum disorders (1) Attention deficit hyperactivity disorder (3) |